Alyeska Investment Group
DGX icon

Alyeska Investment Group’s Quest Diagnostics DGX Stock Holding History

Alyeska Investment Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-375,000
Closed -$51.7M – 501
2023
Q4 		$51.7M Buy
+375,000
New +$49.3M 0.34% 94
2022
Q3 		– Sell
-365,929
Closed -$48.7M – 404
2022
Q2 		$48.7M Buy
+365,929
New +$49.9M 0.56% 47
2020
Q4 		– Sell
-43,389
Closed -$4.97M – 528
2020
Q3 		$4.97M Sell
43,389
-43,547
-50% -$5.15M 0.08% 265
2020
Q2 		$9.91M Buy
+86,936
New +$9.22M 0.15% 199
2018
Q3 		– Sell
-742,632
Closed -$81.6M – 428
2018
Q2 		$81.6M Sell
742,632
-119,007
-14% -$12.4M 0.73% 34
2018
Q1 		$86.4M Buy
+861,639
New +$88.2M 0.72% 39
2016
Q3 		– Sell
-228,465
Closed -$18.6M – 474
2016
Q2 		$18.6M Buy
+228,465
New +$17.4M 0.17% 193
2015
Q1 		– Sell
-17,995
Closed -$1.21M – 507
2014
Q4 		$1.21M Buy
+17,995
New +$1.14M 0.02% 382

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alyeska Investment Group's DGX Position: Q1 2024 in Review

Alyeska Investment Group sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 375,000 shares — an estimated $51.7M sold.

Alyeska Investment Group first reported a position in DGX in Q4 2014 and held it in 8 quarters. The position peaked at $86.4M in Q1 2018. 818 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

  • Alyeska Investment Group reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
  • Alyeska Investment Group sold 375,000 Quest Diagnostics shares in Q1 2024, an estimated $51.7M.
  • Alyeska Investment Group first reported a position in Quest Diagnostics in Q4 2014 and held it in 8 quarters.
  • Alyeska Investment Group's Quest Diagnostics position peaked at $86.4M in Q1 2018.
  • 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Alyeska Investment Group's 13F filing for Q1 2024, filed 15 May 2024.